SPAC5H10.10 Antibody

What is SPAC5H10.10 and why is it significant in research?

SPAC5H10.10 is a gene encoding a predicted NADPH dehydrogenase in Schizosaccharomyces pombe (fission yeast), a model organism widely used in molecular and cell biology research . The protein is significant due to its potential role in cellular redox reactions and NADPH metabolism, which are fundamental to numerous cellular processes including oxidative stress responses, biosynthetic pathways, and cellular detoxification mechanisms. Antibodies against SPAC5H10.10 enable researchers to study protein expression, localization, and function in various experimental contexts, contributing to our understanding of NADPH-dependent processes in eukaryotic cells. The gene identifier Q09671 indicates its entry in the UniProt database, providing researchers with access to further sequence and functional information about this protein .

How should researchers validate SPAC5H10.10 antibody specificity?

Antibody validation is essential for ensuring experimental reliability. For SPAC5H10.10 antibody, a multi-tiered validation approach is recommended. Begin with Western blot analysis using wild-type S. pombe lysates alongside a knockout or knockdown control where SPAC5H10.10 expression is eliminated or reduced. The antibody should detect a band of the expected molecular weight (as predicted from the amino acid sequence) in wild-type samples but show reduced or absent signal in knockout/knockdown samples. Complementary validation techniques include immunoprecipitation followed by mass spectrometry to confirm the identity of pulled-down proteins, immunofluorescence comparing staining patterns in wild-type versus knockout cells, and peptide competition assays where pre-incubation with the antigenic peptide should abolish specific staining . Researchers should document validation experiments thoroughly, as validation parameters may vary based on specific experimental applications.

What sample preparation protocols yield optimal results with SPAC5H10.10 antibody?

Sample preparation significantly influences antibody performance. For SPAC5H10.10 antibody in S. pombe research, consider these methodological guidelines: For protein extraction, use buffer systems that preserve protein structure while efficiently lysing yeast cells (typically containing zymolase or mechanical disruption methods). The buffer composition should maintain NADPH dehydrogenase activity, typically including protease inhibitors, phosphatase inhibitors if studying phosphorylation states, and avoiding strong denaturants for native applications. Cell fixation for immunocytochemistry typically requires optimization between preserving antigen accessibility and maintaining cellular architecture—start with 3.7% formaldehyde fixation for 10-15 minutes at room temperature, followed by permeabilization with 0.1% Triton X-100. For membrane proteins or challenging epitopes, test alternative fixatives like methanol or acetone. During experimental design planning, include appropriate controls for each preparation method to identify potential artifacts or non-specific interactions .

What are the common pitfalls when using SPAC5H10.10 antibody in Western blotting?

Western blotting with SPAC5H10.10 antibody requires careful optimization to avoid several common technical challenges. First, S. pombe cell walls are notoriously tough, potentially leading to incomplete protein extraction; use glass bead disruption or enzymatic methods with optimization for complete lysis. Second, non-specific binding may occur, particularly with polyclonal antibodies; implement stringent blocking (5% non-fat milk or BSA) and consider increasing washing stringency with higher detergent concentrations. Third, NADPH dehydrogenases may form complexes with other proteins, potentially affecting epitope accessibility; sample denaturation conditions should be carefully optimized (varying SDS concentrations and heating times). Fourth, post-translational modifications may affect antibody recognition; consider phosphatase treatment if phosphorylation is suspected to interfere with detection. Finally, transfer efficiency for membrane proteins can be problematic; optimize transfer conditions using gradient gels and testing different membrane types (PVDF versus nitrocellulose). Methodologically, always include positive and negative controls, and consider testing multiple antibody dilutions in preliminary experiments .

How can SPAC5H10.10 antibody be effectively used in immunofluorescence studies?

Immunofluorescence with SPAC5H10.10 antibody in S. pombe requires a systematic approach to generate reliable subcellular localization data. Begin with fixation optimization, testing protocols that preserve both cellular architecture and epitope accessibility. For S. pombe, start with 3.7% formaldehyde fixation for 15 minutes, followed by cell wall digestion using zymolyase treatment (1mg/ml for 30-45 minutes at 37°C). Permeabilization conditions should be carefully optimized—typically 0.1% Triton X-100 for 10 minutes works well for many applications, but membrane proteins may require gentler detergents like digitonin. Blocking should be robust (3-5% BSA in PBS with 0.1% Tween-20) to minimize background. Primary antibody incubation often works best overnight at 4°C at dilutions ranging from 1:100 to 1:1000, but this requires empirical determination. For co-localization studies, combine SPAC5H10.10 antibody with markers for organelles where NADPH dehydrogenases typically function (mitochondria, ER, or cytosol). Always include a negative control (secondary antibody only) and a positive control (antibody against a well-characterized protein with known localization pattern) .

How can researchers optimize co-immunoprecipitation protocols for studying SPAC5H10.10 protein interactions?

Co-immunoprecipitation (Co-IP) with SPAC5H10.10 antibody requires methodical optimization to preserve native protein interactions. Begin by selecting an appropriate lysis buffer that maintains protein complex integrity; for NADPH dehydrogenases, a non-denaturing buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% NP-40 or 0.5% Triton X-100, supplemented with protease inhibitors and 1-2mM DTT to protect thiol groups often yields good results. Cell disruption should be gentle—typically using glass bead lysis with brief vortexing cycles. Pre-clearing the lysate with protein A/G beads reduces non-specific binding. For the IP step itself, determine the optimal antibody-to-lysate ratio empirically, starting with approximately 2-5μg antibody per 500μg total protein. Consider crosslinking the antibody to beads using dimethyl pimelimidate to prevent antibody co-elution with target proteins. Washing conditions represent a critical balance—stringent enough to remove non-specific binders but gentle enough to preserve genuine interactions; typically 4-5 washes with decreasing salt concentrations work well. For elution, compare specific peptide elution versus boiling in SDS sample buffer to determine which method best preserves interaction partners for downstream analysis. Validate interactions using reciprocal IPs and include IgG controls to identify non-specific binding .

What approaches help resolve inconsistent results when using SPAC5H10.10 antibody across different experimental systems?

Inconsistent results with SPAC5H10.10 antibody across different experimental systems can be systematically addressed through a comprehensive troubleshooting approach. First, conduct epitope mapping to understand exactly which region of the protein your antibody recognizes—this may reveal sensitivity to protein conformation or post-translational modifications that vary between experimental conditions. Second, perform Western blot analysis under both reducing and non-reducing conditions; NADPH dehydrogenases often contain disulfide bonds that may affect epitope accessibility. Third, evaluate buffer compatibility issues by testing the antibody's performance across different pH ranges (pH 6.0-8.0) and salt concentrations (100-500mM NaCl). Fourth, assess the impact of different detergents on epitope accessibility, comparing results with Triton X-100, NP-40, CHAPS, and digitonin. Fifth, consider expression level variations across different growth phases or stress conditions when working with S. pombe. Sixth, implement a titration series for both primary and secondary antibodies in each experimental system to identify optimal concentrations. Finally, cross-validate results using a complementary detection method such as mass spectrometry or an alternative antibody targeting a different epitope of SPAC5H10.10 .

How should researchers design experiments to study post-translational modifications of SPAC5H10.10?

Post-translational modifications (PTMs) of SPAC5H10.10 require specialized experimental approaches that build upon standard immunological techniques. Begin by surveying potential modification sites using bioinformatic prediction tools and published PTM databases. For phosphorylation studies, implement a dual-method approach: first, treat samples with phosphatase inhibitors (50mM NaF, 10mM Na₃VO₄) during extraction and compare with phosphatase-treated controls to identify mobility shifts on Western blots. Second, enrich phosphorylated proteins using immobilized metal affinity chromatography (IMAC) or titanium dioxide before immunoprecipitation with SPAC5H10.10 antibody. For detecting ubiquitination, include deubiquitinase inhibitors (NEM or IAA) in lysis buffers and perform immunoprecipitation under denaturing conditions to disrupt non-covalent interactions. To study other modifications like acetylation or methylation, incorporate HDAC inhibitors or methyltransferase inhibitors respectively during sample preparation. Confirmation of specific modifications should employ mass spectrometry analysis of immunoprecipitated SPAC5H10.10, focusing on generating modification-specific fragment ions. For all PTM studies, design time-course experiments that capture the dynamic nature of these modifications under relevant physiological or stress conditions .

How can cross-reactivity issues with SPAC5H10.10 antibody be identified and addressed?

Cross-reactivity issues with SPAC5H10.10 antibody can significantly impact experimental outcomes and require systematic investigation and resolution. Identification of cross-reactivity begins with comprehensive Western blot analysis using lysates from wild-type and SPAC5H10.10 knockout/knockdown S. pombe strains; bands appearing in both samples indicate potential cross-reactive proteins. Cross-reactivity can also be assessed through immunoprecipitation followed by mass spectrometry to identify all captured proteins. To address identified cross-reactivity, implement these methodological approaches: 1) Increase antibody specificity through affinity purification against the specific epitope used for immunization; 2) Pre-absorb the antibody with lysates from knockout cells to deplete cross-reactive antibodies; 3) Implement more stringent washing conditions during immunoprecipitation procedures; 4) Use competitive blocking with peptides corresponding to the epitope; 5) Consider using monoclonal antibodies which typically exhibit higher specificity than polyclonal antibodies. For closely related proteins like SPAC5H10.04, which is also annotated as a predicted NADPH dehydrogenase in S. pombe, perform sequence alignment to identify unique regions that could serve as specific epitopes for antibody generation or for discriminating between family members in data analysis .

How can researchers integrate SPAC5H10.10 antibody into multi-omics approaches?

Integrating SPAC5H10.10 antibody into multi-omics frameworks requires sophisticated experimental design that bridges immunological techniques with other high-throughput methodologies. Begin by implementing sequential or parallel workflows that combine antibody-based enrichment with downstream omics analyses. For example, immunoprecipitation of SPAC5H10.10 followed by mass spectrometry (IP-MS) can identify protein interaction networks, while simultaneously performing RNA-seq on the same biological samples to correlate protein interactions with transcriptional responses. To integrate with metabolomics, design experiments where cells are subjected to metabolic perturbations followed by both metabolite profiling and SPAC5H10.10 immunoprecipitation to correlate protein complex formation with metabolic states. For spatially-resolved multi-omics, combine immunofluorescence of SPAC5H10.10 with fluorescence-activated cell sorting (FACS) to isolate subcellular compartments for subsequent proteomics or metabolomics analysis. When analyzing multi-omics datasets, implement computational integration using correlation networks, multivariate statistical methods, and machine learning approaches to identify emergent patterns. Crucially, design experiments with appropriate biological and technical replicates to support robust statistical analysis across multiple data types, and standardize sample processing workflows to minimize technical variation that could confound biological interpretation .

What experimental design considerations apply when using SPAC5H10.10 antibody to study protein dynamics during stress responses?

Studying SPAC5H10.10 protein dynamics during stress responses requires experimental designs that capture temporal, spatial, and interaction-based changes. As a predicted NADPH dehydrogenase, SPAC5H10.10 may play important roles in redox homeostasis during oxidative stress, making this a particularly relevant research direction. First, design time-course experiments with appropriate sampling intervals (typically logarithmic rather than linear time points) to capture both rapid and delayed responses. Second, implement live-cell imaging using tagged versions of SPAC5H10.10 alongside the antibody-based approaches to validate dynamics in real-time. Third, develop pulse-chase experiments using metabolic labeling (e.g., SILAC) combined with immunoprecipitation to measure protein synthesis and degradation rates under stress conditions. Fourth, apply proximity labeling techniques (BioID or APEX) with SPAC5H10.10 as the bait to capture transient stress-induced interactions. Fifth, design microfluidic experiments that allow precise control of stress application while performing real-time microscopy. For each stress condition (oxidative, temperature, nutrient deprivation), include appropriate controls including a non-stressed time-matched control to account for cell-cycle related changes, and a control strain with a mutated form of SPAC5H10.10 lacking enzymatic activity to distinguish between structural and catalytic roles in stress response .

How can SPAC5H10.10 antibody be effectively used in quantitative proteomics studies?

Quantitative proteomics with SPAC5H10.10 antibody requires careful experimental design and specialized methodological considerations. For absolute quantification of SPAC5H10.10, implement AQUA (Absolute QUAntification) by spiking isotopically-labeled peptide standards corresponding to unique SPAC5H10.10 sequences into your samples prior to MS analysis. For studying SPAC5H10.10 in protein complexes, combine immunoprecipitation with TMT (Tandem Mass Tag) or iTRAQ (Isobaric Tags for Relative and Absolute Quantification) labeling to compare complex composition across different conditions. When analyzing post-translational modifications, enrich modified peptides using techniques like IMAC (phosphorylation) or lectin affinity (glycosylation) before MS analysis. To study protein turnover, combine pulse-chase SILAC labeling with immunoprecipitation, allowing measurement of synthesis and degradation rates. For spatial proteomics, implement hyperLOPIT (hyperplexed Localization of Organelle Proteins by Isotope Tagging) with antibody validation of SPAC5H10.10 localization. Critical controls include: performing parallel experiments with isotype-matched IgG, including spike-in standards for normalization across experiments, and validating key findings using orthogonal techniques like Western blotting. Data analysis should employ appropriate normalization methods, statistical testing with multiple comparison correction, and visualization techniques that effectively communicate quantitative changes in protein abundance, localization, or modification .

What approaches can resolve conformational epitope recognition challenges with SPAC5H10.10 antibody?

Conformational epitope recognition challenges with SPAC5H10.10 antibody can significantly impact experimental outcomes, particularly since NADPH dehydrogenases often undergo conformational changes during catalytic cycles. Address these challenges through a multi-faceted approach: First, perform epitope mapping using hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify which regions of SPAC5H10.10 are recognized by the antibody under native conditions. Second, test antibody binding under different cofactor states (with/without NADPH/NADP+) to determine if catalytic state affects epitope accessibility. Third, implement computational modeling of SPAC5H10.10 structure based on homologous NADPH dehydrogenases to predict surface-exposed regions and potential conformational changes. Fourth, perform binding studies at different temperatures to identify potential temperature-dependent conformational changes affecting epitope recognition. Fifth, develop a panel of monoclonal antibodies targeting different epitopes to ensure at least one antibody will recognize the protein regardless of conformation. Sixth, consider using nanobodies or single-chain antibodies which can sometimes access epitopes unavailable to conventional antibodies. Finally, validate findings using orthogonal techniques like limited proteolysis combined with mass spectrometry to correlate conformational states with antibody recognition patterns .

How should researchers design experiments to explore potential non-canonical functions of SPAC5H10.10?

Investigating non-canonical functions of SPAC5H10.10 beyond its predicted NADPH dehydrogenase activity requires experimental designs that probe diverse cellular processes while maintaining rigorous controls. First, implement proximity-dependent biotinylation (BioID or TurboID) with SPAC5H10.10 as bait to identify protein interactions in different cellular compartments, potentially revealing unexpected associations. Second, perform subcellular fractionation followed by Western blotting with SPAC5H10.10 antibody to detect localization to unexpected cellular compartments. Third, design genetic interaction screens using synthetic genetic array (SGA) methodology with SPAC5H10.10 deletion/mutation strains to identify functional relationships with genes involved in diverse cellular processes. Fourth, implement CRISPR interference or activation to modulate SPAC5H10.10 expression and monitor effects on various cellular pathways through transcriptomics or phenotypic assays. Fifth, create domain deletion mutants to separate canonical enzymatic functions from potential protein-protein interaction domains, expressing these in SPAC5H10.10 knockout backgrounds to assess rescue of specific phenotypes. For all approaches, incorporate appropriate controls including catalytically-dead mutants (for separating structural from enzymatic roles) and closely related family members like SPAC5H10.04 (another predicted NADPH dehydrogenase) to determine specificity of observed non-canonical functions .

How can humanization approaches inform antibody development against conserved targets like SPAC5H10.10?

Though SPAC5H10.10 is a yeast protein, lessons from antibody humanization provide valuable insights for generating optimal research reagents against conserved targets. When developing antibodies against highly conserved proteins like NADPH dehydrogenases, researchers must balance specificity with cross-reactivity across model organisms. The humanization process illustrates how framework selection significantly impacts antibody performance. For SPAC5H10.10 antibody development, consider implementing a structural approach similar to humanization protocols: first, identify the most divergent epitopes between SPAC5H10.10 and related NADPH dehydrogenases in other organisms through computational analysis. Second, consider the length of complementarity-determining regions (CDRs), as shorter CDR H2 regions consistently demonstrate higher thermostability, an important factor for applications requiring native conditions. Third, pay careful attention to Vernier zone residues, though some traditionally critical positions (like residue 71 in the heavy chain) may tolerate substitutions without affecting binding. Fourth, when selecting antibody frameworks, be cautious of potential destabilizing mutations—for example, the IGHV1-2*01 germline has been identified as potentially problematic due to destabilizing mutations compared to other alleles. These structural considerations derived from humanization studies can significantly improve antibody performance in challenging applications like ChIP or native immunoprecipitation .

What experimental approaches can determine if SPAC5H10.10 undergoes tissue factor-like signaling pathways?

While SPAC5H10.10 is a predicted NADPH dehydrogenase in yeast, exploring potential signaling roles analogous to tissue factor pathways requires specific experimental approaches. First, develop phospho-specific antibodies targeting potential phosphorylation sites in SPAC5H10.10 identified through bioinformatic prediction or phosphoproteomics data. Second, implement proximity ligation assays (PLA) to detect in situ interactions between SPAC5H10.10 and components of known signaling pathways. Third, design kinase inhibitor screens to identify signaling cascades that might regulate SPAC5H10.10 function or localization. Fourth, create phosphomimetic and phosphodeficient mutants of SPAC5H10.10 at candidate sites and assess functional consequences through complementation studies. Fifth, perform temporal phosphoproteomics following stimulus application (e.g., oxidative stress) to map potential signaling events involving SPAC5H10.10. Sixth, investigate potential similarities to tissue factor signaling by examining if SPAC5H10.10, like tissue factor, plays dual roles in enzymatic activity and signaling through careful separation of these functions via domain-specific mutations. Seventh, assess if SPAC5H10.10 signaling impacts processes analogous to angiogenesis and growth in yeast, such as pseudohyphal growth or colony formation patterns .

How can researchers effectively integrate SPAC5H10.10 antibody into high-throughput screening approaches?

Integrating SPAC5H10.10 antibody into high-throughput screening requires systematic adaptation of immunological techniques to automated platforms. First, develop a robust solid-phase antibody-based assay, typically ELISA or analogous microplate formats, optimizing antibody concentration, incubation times, and detection systems for consistency across large sample numbers. Second, implement multiplexed approaches by combining SPAC5H10.10 antibody with antibodies against other proteins of interest using differentially labeled secondary antibodies or detection systems. Third, adapt immunofluorescence protocols for high-content screening using automated microscopy, focusing on optimized fixation and permeabilization conditions that maintain consistent epitope accessibility across all samples. Fourth, develop flow cytometry protocols using SPAC5H10.10 antibody for screens requiring single-cell resolution. Fifth, create reporter systems where SPAC5H10.10 antibody binding triggers a detectable signal, such as split-luciferase complementation assays. For quality control, implement Z'-factor analysis across multiple plates to ensure assay robustness, use positive and negative controls on every plate, and develop computational pipelines for automated image analysis when using microscopy-based approaches. Additionally, consider developing homogeneous assay formats like AlphaLISA or TR-FRET to minimize washing steps and increase throughput .

What considerations apply when designing experiments to study SPAC5H10.10 in different genetic backgrounds?

Studying SPAC5H10.10 across different genetic backgrounds requires methodological approaches that account for strain-specific variations in protein expression, function, and regulation. First, implement a systematic verification of antibody specificity across all genetic backgrounds, as epitope accessibility or post-translational modifications might vary between strains. Second, normalize protein expression data relative to multiple housekeeping proteins validated for stability across your specific genetic backgrounds, as common loading controls may vary between strains. Third, create isogenic strains where only the gene of interest differs to minimize confounding genetic factors. Fourth, implement reciprocal hemizygosity analysis when studying heterozygous diploid backgrounds to determine allele-specific effects. Fifth, design experimental replicates that account for both biological variability (different isolates of the same genotype) and technical variability (repeated measurements of the same sample). Sixth, when comparing SPAC5H10.10 function across distantly related strains, complement expression studies with functional assays specific to NADPH dehydrogenase activity. Seventh, implement CRISPR-based approaches to create identical mutations across different genetic backgrounds when studying specific functional domains. Finally, use whole-genome sequencing to identify potential modifier loci that might explain strain-specific differences in SPAC5H10.10 function or regulation .

How can contradictory results between different detection methods for SPAC5H10.10 be resolved?

Resolving contradictory results between different detection methods for SPAC5H10.10 requires systematic troubleshooting and reconciliation approaches. First, implement a comparative epitope mapping study to determine if different antibodies or detection methods recognize distinct regions of SPAC5H10.10, potentially explaining discrepancies if the protein undergoes processing, conformational changes, or masking in complexes. Second, verify antibody specificity across all methods using knockout controls and peptide competition assays. Third, assess method-specific artifacts by comparing native versus denaturing conditions, as some techniques (Western blotting) use denatured proteins while others (immunofluorescence) often maintain native conformation. Fourth, examine buffer incompatibilities by systematically testing components from each method's buffer system for interference with other detection approaches. Fifth, implement orthogonal methods that don't rely on antibodies, such as mass spectrometry or activity assays specific to NADPH dehydrogenases, to provide independent verification. Sixth, consider temporal dynamics—contradictory results might reflect real biological differences in protein state at different time points or under different conditions. For comprehensive reconciliation, design unified experimental workflows where the same biological samples are processed in parallel through multiple detection methods, allowing direct comparison while minimizing sample preparation variables .

What future directions should researchers consider for SPAC5H10.10 antibody applications?

Future research directions for SPAC5H10.10 antibody applications should focus on advancing both technological capabilities and biological understanding. Methodologically, researchers should consider developing conformation-specific antibodies that selectively recognize SPAC5H10.10 in different enzymatic states (NADPH-bound versus unbound), enabling dynamic studies of protein function. Single-domain antibodies (nanobodies) against SPAC5H10.10 would facilitate live-cell imaging and potentially modulate protein function in vivo. Integration of SPAC5H10.10 antibodies with emerging spatial transcriptomics and proteomics techniques could reveal localized function in different cellular compartments. Biologically, researchers should investigate potential moonlighting functions of SPAC5H10.10 beyond its predicted NADPH dehydrogenase activity, particularly in stress response pathways where redox enzymes often play regulatory roles. Comparative studies across different yeast species could illuminate evolutionary conservation of SPAC5H10.10 function. Additionally, developing modified antibodies that selectively recognize post-translationally modified forms of SPAC5H10.10 would enable studies of regulation through PTMs. Finally, creating systems biology models incorporating SPAC5H10.10 interaction networks identified through antibody-based approaches would provide a framework for understanding its role in broader cellular contexts .